Gainers
- Protara Therapeutics (NASDAQ:TARA) stock rose 168.9% to $9.52 during Thursday's pre-market session. The company's market cap stands at $196.3 million.
- Bluejay Diagnostics (NASDAQ:BJDX) stock moved upwards by 67.86% to $6.53. The market value of their outstanding shares is at $3.6 million.
- Psyence Biomedical (NASDAQ:PBM) stock moved upwards by 30.95% to $3.3. The market value of their outstanding shares is at $2.7 million.
- Capricor Therapeutics (NASDAQ:CAPR) stock increased by 16.43% to $14.81. The company's market cap stands at $673.4 million.
- Adverum Biotechnologies (NASDAQ:ADVM) stock increased by 15.0% to $6.9. The company's market cap stands at $143.5 million.
- CervoMed (NASDAQ:CRVO) stock increased by 13.38% to $11.0. The market value of their outstanding shares is at $90.7 million.
Losers
- bluebird bio (NASDAQ:BLUE) stock fell 32.4% to $0.5 during Thursday's pre-market session. The company's market cap stands at $96.8 million.
- Cyclerion Therapeutics (NASDAQ:CYCN) stock declined by 24.26% to $4.81. The company's market cap stands at $13.0 million.
- BioRestorative Therapies (NASDAQ:BRTX) stock declined by 12.0% to $1.32. The company's market cap stands at $9.1 million.
- Envoy Medical (NASDAQ:COCH) stock decreased by 11.91% to $1.85. The market value of their outstanding shares is at $37.4 million.
- Marker Therapeutics (NASDAQ:MRKR) shares decreased by 11.08% to $3.13. The market value of their outstanding shares is at $27.9 million.
- Stevanato Group (NYSE:STVN) stock decreased by 10.5% to $18.0. The company's market cap stands at $4.9 billion.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
